HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free All Versions of this Article: 102/3/949    most recent 01048.2006v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Zhang, J. Articles by Fallon, M. B. Search for Related Content PubMed PubMed Citation Articles by Zhang, J. Articles by Fallon, M. B.

Pentoxifylline attenuation of experimental hepatopulmonary syndrome

¹Division of Gastroenterology, University of Alabama at Birmingham, and ²Department of Pathology, University of Alabama at Birmingham ³Birmingham Veterans Administration Medical Center, Birmingham, Alabama

Submitted 19 September 2006 ; accepted in final form 10 November 2006

Hepatopulmonary syndrome (HPS) following rat common bile duct ligation results from pulmonary molecular changes that may be influenced by circulating TNF- and increased vascular shear stress, through activation of NF-B or Akt. Increased pulmonary microvascular endothelin B (ET_B) receptor and endothelial nitric oxide synthase (eNOS) levels contribute to nitric oxide production and the development of experimental HPS. Pentoxifylline (PTX), a phosphodiesterase and nonspecific TNF- inhibitor, ameliorates experimental HPS when begun before hepatic injury. However, how PTX influences the molecular events associated with initiation of experimental HPS after liver injury is established is unknown. We assessed the effects of PTX on the molecular and physiological features of HPS in vivo and on shear stress or TNF--mediated events in rat pulmonary microvascular endothelial cells in vitro. PTX significantly improved HPS without altering portal or systemic hemodynamics and downregulated pulmonary ET_B receptor levels and eNOS expression and activation. These changes were associated with a reduction in circulating TNF levels and NF-B activation and complete inhibition of Akt activation. In rat pulmonary microvascular endothelial cells, PTX inhibited shear stress-induced ET_B receptor and eNOS expression and eNOS activation. These effects were also associated with inhibition of Akt activation and were reproduced by wortmanin. In contrast, TNF- had no effects on endothelial ET_B and eNOS alterations in vitro. PTX has direct effects in the pulmonary microvasculature, likely mediated through Akt inhibition, that ameliorate experimental HPS.

common bile duct ligation; endothelial cells; endothelin B receptor; endothelial nitric oxide synthase

This article has been cited by other articles:

				L. B. Gupta, A. Kumar, A. K. Jaiswal, J. Yusuf, V. Mehta, S. Tyagi, D. K. Tempe, B. C. Sharma, and S. K. Sarin Pentoxifylline Therapy for Hepatopulmonary Syndrome: A Pilot Study Arch Intern Med, September 8, 2008; 168(16): 1820 - 1823. [Full Text] [PDF]

				R. Rodriguez-Roisin and M. J. Krowka Hepatopulmonary Syndrome -- A Liver-Induced Lung Vascular Disorder N. Engl. J. Med., May 29, 2008; 358(22): 2378 - 2387. [Full Text] [PDF]